A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs

[1] Simionatto S(2013)Mycoplasma hyopneumoniae: from disease to vaccine development Vet Microbiol 165 234-242

[2] Marchioro SB(2008)Control of Mycoplasma hyopneumoniae infections in pigs Vet Microbiol 126 297-309

[3] Maes D(2015)Revisiting the taxonomical classification of porcine Circovirus type 2 (PCV-2): still a real challenge Virol J 12 131-4037

[4] Dellagostin OA(2009)One dose of a porcine circovirus 2 (PCV-2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model Vaccine 27 4031-19

[5] Maes D(2012)Porcine circovirus type 2 (PCV-2) infections: clinical signs, pathology and laboratory diagnosis Virus Res 164 10-118

[6] Segales J(2015)Porcine circovirus 2 immunology and viral evolution PHM 1 17-42

[7] Meyns T(2013)Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms Prev Vet Med 110 103-120

[8] Sibila M(2012)Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV-2) Virus Res 164 33-234

[9] Pieters M(2014)Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets BMC Vet Res 10 124-1992

[10] Haesebrouck F(2014)Colostral antibody-mediated and cell-mediated immunity contributes to innate and antigen-specific immunity in piglets Dev Comp Immunol 43 114-380

[1] Simionatto S(2013)Mycoplasma hyopneumoniae: from disease to vaccine development Vet Microbiol 165 234-242

[2] Marchioro SB(2008)Control of Mycoplasma hyopneumoniae infections in pigs Vet Microbiol 126 297-309

[3] Maes D(2015)Revisiting the taxonomical classification of porcine Circovirus type 2 (PCV-2): still a real challenge Virol J 12 131-4037

[4] Dellagostin OA(2009)One dose of a porcine circovirus 2 (PCV-2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model Vaccine 27 4031-19

[5] Maes D(2012)Porcine circovirus type 2 (PCV-2) infections: clinical signs, pathology and laboratory diagnosis Virus Res 164 10-118

[6] Segales J(2015)Porcine circovirus 2 immunology and viral evolution PHM 1 17-42

[7] Meyns T(2013)Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms Prev Vet Med 110 103-120

[8] Sibila M(2012)Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV-2) Virus Res 164 33-234

[9] Pieters M(2014)Maternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in piglets BMC Vet Res 10 124-1992

[10] Haesebrouck F(2014)Colostral antibody-mediated and cell-mediated immunity contributes to innate and antigen-specific immunity in piglets Dev Comp Immunol 43 114-380